Dan Edwall
Amministratore Delegato presso Doktor Edwall AB
Profilo
Dan Edwall is currently the Chief Executive Officer at Doktor Edwall AB, Chairman at BioFood Medica AB, and Vice President-Research & Development at Scandivir AB.
He previously worked as Vice President-Research & Development at Nimutan AB and NattoPharma ASA. Dr. Edwall holds a doctorate degree from Karolinska Institutet.
Posizioni attive di Dan Edwall
| Società | Posizione | Inizio |
|---|---|---|
| BioFood Medica AB | Presidente | 01/07/2011 |
| Doktor Edwall AB | Amministratore Delegato | 01/07/2011 |
| Scandivir AB | Direttore Tecnico/Scientifico/R&S | 01/07/2011 |
Precedenti posizioni note di Dan Edwall
| Società | Posizione | Fine |
|---|---|---|
| NIMUTAN AB (PUBL) | Direttore Tecnico/Scientifico/R&S | - |
| NATTOPHARMA ASA | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Dan Edwall
| Karolinska Institutet | Doctorate Degree |
Esperienze
Posizioni ricoperte
Società collegate
| Aziende private | 5 |
|---|---|
Nimutan AB
 Nimutan AB Household/Personal CareConsumer Non-Durables Nimutan AB engages in the development, marketing, and sale of nutritional products and food supplements. It operates through the following segments: Brand Sales; Production, Innovation, and Private Label; and Corporate. It sells a variety of products for men and women's health, joint health, and skin care. The company was founded by Bengt Johansson on November 15, 2005 and is headquartered in Jönköping, Sweden. | Consumer Non-Durables |
NattoPharma ASA
 NattoPharma ASA Pharmaceuticals: MajorHealth Technology NattoPharma ASA engages in the manufacture and sale of nutritional and pharmaceutical products. It offers vitamin K2 under the product brand MenaQ7. The company was founded by Frode Marc Bohan on November 4, 2004 and is headquartered in Oslo, Norway. | Health Technology |
| Scandivir AB | |
| BioFood Medica AB | |
| Doktor Edwall AB |
- Borsa valori
- Insiders
- Dan Edwall